T-group (topology)

1075.1.1 ABCG5/ABCG8 transmembrane domain

Open in classification tree →

Ligands and drugs

2,138

Member domains

180

with ligand contacts (≤ 4 Å)

8.4% of members

with DrugDomain annotations

4.4% of members

with a DrugBank compound

3.4% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

Chemical profiles are computed for X-groups. 1075.1.1 belongs to X-group 1075 Type II ABC exporter transmembrane domain fold, which binds 8.7 ligand superclasses per 20 proteins, broader than 72% of the 256 X-groups with enough proteins to compare. View its chemical profile →

DrugBank compounds

DrugBank	PDB ligand	Name	Domains
DB04540	CLR	Cholesterol	34
DB00141	NAG	N-Acetylglucosamine	8
DB00171	ATP	ATP	8
DB01030	TTC	Topotecan	6
DB06240	R1H	Tariquidar	6
DB04327	PEE	Phosphatidylethanolamine	5
DB01204	MIX	Mitoxantrone	4
DB02777	PLC	Diundecyl Phosphatidyl Choline	4
DB07640	DCQ	2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione	4
DB16829	A8S	Abscisic Acid	4
DB16833	ADP	Adenosine disphosphate	3
DB00619	STI	Imatinib	2
DB01016	—	Glyburide	2
DB01599	—	—	2
DB03472	MA4	Cyclohexyl-Hexyl-Beta-D-Maltoside	2
DB04038	ERG	Ergosterol	2
DB05482	RS4	SN-38	2
DB04851	—	—	1
DB08357	P4G	Diethylene glycol diethyl ether	1
DB11995	—	—	1

Most frequently bound compounds

PDB ligand	Name	Domains in contact
CLR	CHOLESTEROL	48
NAG	2-acetamido-2-deoxy-beta-D-glucopyranose	31
JSG	(2~{R},4~{R},5~{R},6~{R})-6-[(1~{R})-1,2-bis(oxidanyl)ethyl]-2-[(2~{R},4~{R},5~{R},6~{R})-6-[(1~{R})-1,2-bis(oxidanyl)ethyl]-5-[(2~{S},3~{S},4~{R},5~{R},6~{R})-6-[(1~{S})-1,2-bis(oxidanyl)ethyl]-4-[(2~{R},3~{S},4~{R},5~{S},6~{R})-6-[(1~{S})-2-[(2~{S},3~{S},4~{S},5~{S},6~{R})-6-[(1~{S})-1,2-bis(oxidanyl)ethyl]-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-1-oxidanyl-ethyl]-3,4-bis(oxidanyl)-5-phosphonooxy-oxan-2-yl]oxy-3-oxidanyl-5-phosphonooxy-oxan-2-yl]oxy-2-carboxy-2-[[(2~{R},3~{S},4~{R},5~{R},6~{R})-5-[[(3~{R})-3-dodecanoyloxytetradecanoyl]amino]-6-[[(2~{R},3~{S},4~{R},5~{R},6~{R})-3-oxidanyl-5-[[(3~{R})-3-oxidanyltetradecanoyl]amino]-4-[(3~{R})-3-oxidanyltetradecanoyl]oxy-6-phosphonooxy-oxan-2-yl]methoxy]-3-phosphonooxy-4-[(3~{R})-3-tetradecanoyloxytetradecanoyl]oxy-oxan-2-yl]methoxy]oxan-4-yl]oxy-4,5-bis(oxidanyl)oxane-2-carboxylic acid	14
3PE	1,2-Distearoyl-sn-glycerophosphoethanolamine	12
A8S	(2Z,4E)-5-[(1S)-1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl]-3-methylpenta-2,4-dienoic acid	8
ATP	ADENOSINE-5'-TRIPHOSPHATE	8
BWQ	~{tert}-butyl 3-[(2~{S},5~{S},8~{S})-14-cyclopentyloxy-2-(2-methylpropyl)-4,7-bis(oxidanylidene)-3,6,17-triazatetracyclo[8.7.0.0^{3,8}.0^{11,16}]heptadeca-1(10),11,13,15-tetraen-5-yl]propanoate	8
ADP	ADENOSINE-5'-DIPHOSPHATE	7
R1H	tariquidar	6
TTC	(S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE	6
Y01	CHOLESTEROL HEMISUCCINATE	6
PEE	1,2-dioleoyl-sn-glycero-3-phosphoethanolamine	5
POV	(2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate	5
AOV	ADP ORTHOVANADATE	4
DCQ	2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione	4
FY5	estrone 3-sulfate	4
HZL	[(2S)-3-[2-[(E)-[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenylidene]amino]ethoxy-oxidanyl-phosphoryl]oxy-2-[(Z)-octadec-9-enoyl]oxy-propyl] (Z)-octadec-9-enoate	4
KJ9	(2R,5S,8S)-2,5-dihydroxy-5,10-dioxo-8-[(undecanoyloxy)methyl]-4,6,9-trioxa-5lambda~5~-phosphahenicosan-1-yl 3-deoxy-alpha-L-altro-oct-2-ulopyranosidonic acid	4
MIX	1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE	4
PLC	DIUNDECYL PHOSPHATIDYL CHOLINE	4